Patients will lose in “Drug War”

The most important viewpoint - that of the patient - has been missing in recent articles such as "Drug war crossfire", the "High stakes showdown", "Marketing the drug culture", patient protection and the various opinions expressed through the media by the pharmaceutical industry, generic drug makers and think tank experts.